Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: margie who wrote (5613)	11/2/1998 10:19:00 AM
From: scaram(o)uche	Read Replies (1) of 6136

Kathleen Whatshername just reported on CNBC. Wo! Patients on amprenavir will only need to take two pills/day, a huge advantage over current protocols, where patients take 20-30 pills/day! (you don't assume that she's listening to the Glaxo line, huh?) Wo! Gosh! Gee, Whillickers!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next